1. Home
  2. RVMD vs ADC Comparison

RVMD vs ADC Comparison

Compare RVMD & ADC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMD
  • ADC
  • Stock Information
  • Founded
  • RVMD 2014
  • ADC 1971
  • Country
  • RVMD United States
  • ADC United States
  • Employees
  • RVMD N/A
  • ADC N/A
  • Industry
  • RVMD Biotechnology: Biological Products (No Diagnostic Substances)
  • ADC Real Estate Investment Trusts
  • Sector
  • RVMD Health Care
  • ADC Real Estate
  • Exchange
  • RVMD Nasdaq
  • ADC Nasdaq
  • Market Cap
  • RVMD 7.5B
  • ADC 8.0B
  • IPO Year
  • RVMD 2020
  • ADC 1994
  • Fundamental
  • Price
  • RVMD $43.81
  • ADC $72.00
  • Analyst Decision
  • RVMD Strong Buy
  • ADC Buy
  • Analyst Count
  • RVMD 16
  • ADC 13
  • Target Price
  • RVMD $73.56
  • ADC $80.88
  • AVG Volume (30 Days)
  • RVMD 2.1M
  • ADC 902.9K
  • Earning Date
  • RVMD 11-05-2025
  • ADC 10-21-2025
  • Dividend Yield
  • RVMD N/A
  • ADC 4.27%
  • EPS Growth
  • RVMD N/A
  • ADC N/A
  • EPS
  • RVMD N/A
  • ADC 1.68
  • Revenue
  • RVMD N/A
  • ADC $659,753,000.00
  • Revenue This Year
  • RVMD N/A
  • ADC $15.43
  • Revenue Next Year
  • RVMD $454.11
  • ADC $10.59
  • P/E Ratio
  • RVMD N/A
  • ADC $42.78
  • Revenue Growth
  • RVMD N/A
  • ADC 13.16
  • 52 Week Low
  • RVMD $29.17
  • ADC $67.58
  • 52 Week High
  • RVMD $62.40
  • ADC $79.65
  • Technical
  • Relative Strength Index (RSI)
  • RVMD 63.22
  • ADC 45.18
  • Support Level
  • RVMD $39.73
  • ADC $71.69
  • Resistance Level
  • RVMD $47.21
  • ADC $74.08
  • Average True Range (ATR)
  • RVMD 1.81
  • ADC 0.97
  • MACD
  • RVMD 0.57
  • ADC -0.02
  • Stochastic Oscillator
  • RVMD 64.77
  • ADC 16.80

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

About ADC Agree Realty Corporation

Agree Realty Corporation operates as a fully integrated real estate investment trust mainly focused on the ownership, acquisition, development and management of retail properties net leased to industry-tenants. The Company is mainly in the business of acquiring, developing and managing retail real estate. Some of its properties in the portfolio include Walmart, 7-Eleven, Wawa, Gerber Collision and others.

Share on Social Networks: